ArticleFrontiers in cardiovascular medicine2022

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention.

Seung-Jun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.